TY - JOUR
TI - In vitro and in vivo activities of chios mastic gum extracts and constituents against Helicobacter pylori
AU - Paraschos, S.
AU - Magiatis, P.
AU - Mitakou, S.
AU - Petraki, K.
AU - Kalliaropoulos, A.
AU - Maragkoudakis, P.
AU - Mentis, A.
AU - Sgouras, D.
AU - Skaltsounis, A.-L.
JO - Antimicrobial Agents and Chemotherapy
PY - 2007
VL - 51
TODO - 2
SP - 551-559
PB - 
SN - 0066-4804, 1098-6596
TODO - 10.1128/AAC.00642-06
TODO - 28 norolean 12 en 3 one;  alcohol derivative;  aldehyde derivative;  dammaradienone;  isomasticadienolic acid;  isomasticadienonic acid;  masticadienoic acid;  masticadienolic acid;  moronic acid;  oleanolic aldehyde;  oleanonic acid;  oleanonic aldehyde;  Pistacia lentiscus extract;  polymer;  resin;  tirucallol;  triterpene derivative;  unclassified drug, animal experiment;  animal model;  animal tissue;  antibacterial activity;  article;  bacterial colonization;  bacterial strain;  chromatography;  chronic gastritis;  chronic inflammation;  concentration response;  controlled study;  drug efficacy;  female;  Helicobacter infection;  Helicobacter pylori;  in vitro study;  in vivo study;  inflammatory infiltrate;  mass spectrometry;  mouse;  nonhuman;  nuclear magnetic resonance imaging;  nuclear Overhauser effect;  Pistacia lentiscus;  priority journal;  separation technique;  solubility;  structure activity relation, Animals;  Dose-Response Relationship, Drug;  Female;  Helicobacter Infections;  Helicobacter pylori;  Mice;  Mice, Inbred C57BL;  Pistacia;  Plant Extracts;  Resins, Plant;  Structure-Activity Relationship
TODO - The extracts and pure major constituents of Chios mastic gum (resin of Pistacia lentiscus var. chia) were tested for their activities against Helicobacter pylori. A total mastic extract without polymer (TMEWP) was prepared after removal of the contained insoluble polymer in order to ameliorate solubility and enhance in vivo activity. Administration of TMEWP to H. pylori SS1-infected mice over the period of 3 months with an average dose of 0.75 mg/day led to an approximately 30-fold reduction in the H. pylori colonization (1.5 log CFU/g of tissue). However, no attenuation in the H. pylori-associated chronic inflammatory infiltration and the activity of chronic gastritis was observed. To further characterize potential active mastic constituents, the TMEWP was separated into an acidic and a neutral fraction. Both were extensively characterized by nuclear magnetic resonance and mass spectroscopy to elucidate the structure of the components contained within each fraction. After chromatographic separation, the acid fraction gave the major triterpenic acids, while the neutral fraction gave several triterpenic alcohols and aldehydes. Mastic extracts and isolated pure triterpenic acids were tested for in vitro activity against a panel of 11 H. pylori clinical strains. The acid fraction was found to be the most active extract (minimum bactericidal concentration [MBC], 0.139 mg/ml), and the most active pure compound was isomasticadienolic acid (MBC, 0.202 mg/ml [0.443 mM]). Our results show that administration of TMEWP may be effective in reducing H. pylori colonization and that the major triterpenic acids in the acid extract may be responsible for such an activity. Copyright © 2007, American Society for Microbiology. All Rights Reserved.
ER -